ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,142.15
-0.06%
Dow Jones
38,778.10
0.49%
Gold vs US Dollar
2,319.22
-0.59%
Brent Oil
83.86
2.11%
Bitcoin
66,597.06
-0.06%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Nexien BioPharma Inc (QB) (NXEN)

  7. Nexien BioPharma Inc (QB) (NXEN) News

Nexien BioPharma (QB) (NXEN)

Nexien BioPharma Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:NXEN
DateTimeSourceHeadlineSymbolCompany
28/05/202416:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
28/05/202416:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
15/05/202411:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NXENNexien BioPharma Inc (QB)
20/02/202411:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NXENNexien BioPharma Inc (QB)
14/02/202411:04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:NXENNexien BioPharma Inc (QB)
02/11/202320:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
02/11/202320:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
28/09/202311:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:NXENNexien BioPharma Inc (QB)
31/07/202322:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
31/07/202320:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
15/05/202320:35Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:NXENNexien BioPharma Inc (QB)
19/04/202323:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
19/04/202321:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
08/02/202311:18Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
17/01/202318:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
17/01/202318:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
09/11/202211:22Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
18/10/202217:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
18/10/202216:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
15/09/202221:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
14/09/202222:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
14/09/202222:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
12/05/202217:36Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
08/02/202211:08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
31/01/202220:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
21/01/202218:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NXENNexien BioPharma Inc (QB)
29/11/202117:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
29/11/202117:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
22/11/202114:57Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
12/10/202111:16Edgar (US Regulatory)Annual Report (10-k)USOTC:NXENNexien BioPharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:NXEN

Your Recent History

LSE
EEE
Empire Metals
LSE
BT.A
Bt
LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
VAST
Vast Resources
LSE
ARCM
Arc Minerals
LSE
BIRD
Blackbird
LSE
GKP
Gulf Keystone Petroleum
LSE
SOLG
Solgold
LSE
THG
Thg
LSE
POS
Plexus
LSE
LBE
Longboat Energy
LSE
SDRY
Superdry
LSE
KEFI
Kefi Gold And Copper
LSE
INSG
Insig Ai
LSE
AAZ
Anglo Asian Mining
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved